Streetbeat News

SPRC

SciSparc Ltd.

https://scisparc.com

Industry

Biotechnology

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Shares of SciSparc have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:39 pm

Shares of SciSparc (SPRC) were halted on a circuit breaker to the upside, but the stock is now down by -2.06%.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2023 | 1:35 pm

Several stocks are experiencing significant pre-market movements. Biocept, Inc. (BIOC) surged 91.8% after filing for Chapter 7 bankruptcy. Shift Technologies, Inc. (SFT) rose 74.4% after announcing plans to file for Chapter 11 bankruptcy. Connexa Sports Technologies Inc. (CNXA) gained 45% and RVL Pharmaceuticals plc (RVLP) climbed 41.2% after receiving a delisting notice. Talaris Therapeutics, Inc. (TALS) jumped 8.2% after announcing stockholder approval of a merger with Tourmaline Bio and a 1-for-10 reverse stock split.

Portfolio Pulse from Lisa Levin

October 18, 2023 | 12:19 pm

Bank of America Corp reported better-than-expected earnings for its third quarter, with EPS of $0.90, compared to $0.81 in the year-ago period, beating the consensus of $0.81. Revenue increased 3% year-over-year to $25.32 billion, beating the consensus of $25.14 billion. SciSparc Ltd. shares shot up 122% after Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. Shares of Assembly Biosciences, Inc. got a boost after the company and Gilead announced a 12-year partnership. Olink Holding AB shares were also up after Thermo Fisher Scientific announced it will acquire the company. Evelo Biosciences, Inc. shares dropped 56% after releasing top-line results from its Phase 2 clinical study. Shares of NetScout Systems, Inc. were down after the company reported weak preliminary results for the second quarter and lowered its FY24 guidance. Monte Rosa Therapeutics, Inc. was down after announcing interim data from the Phase 1 dose escalation part of its ongoing phase 1/2 study.

Portfolio Pulse from Lisa Levin

October 17, 2023 | 6:31 pm

The article lists the stocks that gained and lost in Tuesday's mid-day session. Notable gainers include SciSparc Ltd., Assembly Biosciences, Inc., and Olink Holding AB, while notable losers include Evelo Biosciences, Inc., Monte Rosa Therapeutics, Inc., and Nuvve Holding Corp. The article also mentions that ServisFirst Bancshares shares are trading lower by 6% after the company reported third-quarter earnings.

Portfolio Pulse from Lisa Levin

October 17, 2023 | 5:42 pm

The Dow Jones rose by 100 points, while NASDAQ fell slightly. Goldman Sachs reported better-than-expected Q3 earnings, despite a decrease from the previous year. Energy shares climbed by 1%, while IT shares fell by 0.9%. SciSparc, Assembly Biosciences, and Olink Holding saw significant stock increases, while Evelo Biosciences, NetScout Systems, and Monte Rosa Therapeutics experienced decreases. Oil and gold prices rose slightly.

Portfolio Pulse from Lisa Levin

October 17, 2023 | 3:56 pm

SciSparc Ltd. (NASDAQ:SPRC) shares surged after the company announced the closing of a $5 million private placement and regained compliance with the Nasdaq minimum bid price rule. The company issued 1,930,108 units consisting of two pre-funded warrants which are immediately exercisable and have a term of five years. The stock could be experiencing additional volatility due to the ongoing conflict in Israel.

Portfolio Pulse from Erica Kollmann

October 17, 2023 | 3:14 pm

US stocks traded lower with the Nasdaq Composite falling more than 1%. U.S. retail sales rose 0.7% month-over-month in September, beating estimates of a 0.3% increase. Energy shares climbed by 0.6% while information technology shares fell by 2.1%. SciSparc Ltd., Assembly Biosciences, Inc., and Olink Holding AB saw their shares rise significantly. Evelo Biosciences, Inc., NetScout Systems, Inc., and BIO-key International, Inc. saw their shares drop.

Portfolio Pulse from Lisa Levin

October 17, 2023 | 2:01 pm

Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.0 Million Private Placement for SciSparc Ltd. (NASDAQ:SPRC). Gilead Sciences and Assembly Biosciences announced a 12-year partnership for antiviral therapies, with Assembly Bio to receive $100M upfront payment. Wyndham Hotels & Resorts shares are trading higher after Choice Hotels proposed to acquire the company for $90.00 per share.

Portfolio Pulse from ryanfaloona@benzinga.com

October 17, 2023 | 12:42 pm

Shares of Vistagen Therapeutics, Inc. (NASDAQ:VTGN) rose by 12.6% in pre-market trading after Citadel Advisors LLC reported a 5.6% stake in the company. Other notable gainers include SciSparc Ltd. (NASDAQ:SPRC), WiSA Technologies, Inc. (NASDAQ:WISA), and Athersys, Inc. (NASDAQ:ATHX). On the other hand, Nuvve Holding Corp. (NASDAQ:NVVE), NetScout Systems, Inc. (NASDAQ:NTCT), and Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) were among the losers.

Portfolio Pulse from Lisa Levin

October 17, 2023 | 12:12 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.